These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35759402)

  • 1. Characterizing the Heart Rate Effects From Administration of Sugammadex to Reverse Neuromuscular Blockade: An Observational Study in Patients.
    Ebert TJ; Cumming CE; Roberts CJ; Anglin MF; Gandhi S; Anderson CJ; Stekiel TA; Gliniecki R; Dugan SM; Abdelrahim MT; Klinewski VB; Sherman K
    Anesth Analg; 2022 Oct; 135(4):807-814. PubMed ID: 35759402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.
    Rezonja K; Mars T; Jerin A; Kozelj G; Pozar-Lukanovic N; Sostaric M
    BMC Anesthesiol; 2016 Oct; 16(1):101. PubMed ID: 27765010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment.
    Panhuizen IF; Gold SJ; Buerkle C; Snoeck MM; Harper NJ; Kaspers MJ; van den Heuvel MW; Hollmann MW
    Br J Anaesth; 2015 May; 114(5):777-84. PubMed ID: 25829395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis.
    Kim YS; Lim BG; Won YJ; Oh SK; Oh JS; Cho SA
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833477
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial.
    Tassonyi E; Pongrácz A; Nemes R; Asztalos L; Lengyel S; Fülesdi B
    Anesth Analg; 2015 Aug; 121(2):373-80. PubMed ID: 25923435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery.
    Dahl V; Pendeville PE; Hollmann MW; Heier T; Abels EA; Blobner M
    Eur J Anaesthesiol; 2009 Oct; 26(10):874-84. PubMed ID: 19455040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurarization with magnesium sulfate administered after two minutes sugammadex reversal: A randomized, double-blind, controlled trial.
    Germano-Filho PA; Cavalcanti IL; Micuci AJQR; Velarde LGC; de Boer HD; Verçosa N
    J Clin Anesth; 2023 Oct; 89():111186. PubMed ID: 37393856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of variations in depth of neuromuscular blockade on rating of surgical conditions by surgeon and anesthesiologist in patients undergoing laparoscopic renal or prostatic surgery (BLISS trial): study protocol for a randomized controlled trial.
    Boon M; Martini CH; Aarts LP; Bevers RF; Dahan A
    Trials; 2013 Mar; 14():63. PubMed ID: 23452344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A temporary decrease in twitch response following reversal of rocuronium-induced neuromuscular block with a small dose of sugammadex in a pediatric patient.
    Iwasaki H; Takahoko K; Otomo S; Sasakawa T; Kunisawa T; Iwasaki H
    J Anesth; 2014 Apr; 28(2):288-90. PubMed ID: 23963464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate changes following the administration of sugammadex in children: a prospective, observational study.
    Alsuhebani M; Sims T; Hansen JK; Hakim M; Walia H; Miller R; Tumin D; Tobias JD
    J Anesth; 2020 Apr; 34(2):238-242. PubMed ID: 31980926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.